The Cochrane Metabolic and Endocrine Disorders Review Group and its possible impact on the Spanish Society of Diabetes

Seminars of diabetes - Vol.25 N.5  setember-october 2009
B. Richter¹, D. Mauricio²

 Author Affiliations

Abstract

Evidence based medicine means the integration of the best research evidence with clinical expertise and the patient’s unique values and circumstances. Today, nobody seriously questions this concept anymore but strong counterforces try to distort or circumvent this momentum. The Cochrane Collaboration is one of the very few independent organisations of considerable size in medicine trying to establish high-quality systematic reviews and publish these in The Cochrane Library. The Cochrane Metabolic and Endocrine Disorders Group (CMED), one of more than 50 Cochrane Review Groups focuses on systematic reviews of the benefits and harms of healthcare interventions for metabolic and endocrine disorders. A Cochrane review is a formidable challenge but help is provided through all stages of review production by the CMED. More than 500 authors are currently actively participating in our group and helped to create the present impact factor of 5.182. Increased input to Cochrane reviews from a wider range of cultural and socio-economic sectors such as the ‘Hispano side of the world’ would be welcome to provide better information to patients globally.

Correspondence

Correspondencia: Prof. Dr. Bernd Richter, MD, PhD. Coordinating Editor. 
Cochrane Metabolic and Endocrine Disorders Review Group. Department of General Practice.
 University Hospital Duesseldorf. Heinrich-Heine University. Postfach 10 10 07. D-40001 Duesseldorf.
Germany. 
E-mail: richterb@uni-duesseldorf.de. 
http://www.endoc.cochrane.org

Keywords

diabetes mellitus Netting the evidence (EBM) meta-analysis, , Cochrane Review systematic reviews

Document

PDF Document

Seminary

Bibliometry thechniques

‹ Back